EUVIMEDEUVIMED entdecken
Open Access

Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies

Abhay Bavishi, Hardev Vala, Shailesh Thakrar, Sagar Swami, Dhiman Sarkar, Rushit Shukla, Jignesh Kamdar, Anamik Shah

Future Medicinal Chemistry · 2025

DOI: 10.1080/17568919.2025.2504331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2025. Verfasst von Abhay Bavishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Christ College, Rajkot, India. Hauptthemen laut MEDLINE: Coumarins, Antitubercular Agents, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study aimed to synthesize, characterize, and evaluate the antimicrobial and antitubercular activities of two novel series of coumarin-based derivatives (Series 5 and Series 9), focusing on their structure-activity relationship (SAR) and molecular docking interactions with key bacterial enzymes. MATERIALS & METHODS: Series 5 (5a-5j) and Series 9 (9a-9t) compounds were synthesized and characterized using spectroscopic techniques. Their antimicrobial and antitubercular activities were evaluated against Mycobacterium tuberculosis, Staphylococcus aureus, Bacillus subtilis, and E. coli. IC₅₀ values were determined, and molecular docking studies were conducted to assess binding interactions with M. tuberculosis enoyl-ACP reductase (InhA) and E. coli DNA gyrase B. RESULTS: Series 5 compounds exhibited moderate activity, with 5f, 5 g, 5i, and 5j showing notable inhibition. Series 9 derivatives displayed superior dual-target inhibition, with 9t, 9c, 9a, 9b, and 9p achieving >90% inhibition against S. aureus and B. subtilis. The lowest IC₅₀ against M. tuberculosis was observed for 9c (1.50 µg/mL), followed by 9a (2.84 µg/mL) and 9b (2.73 µg/mL). Molecular docking confirmed strong binding interactions, correlating with observed biological activities. CONCLUSIONS: Series 9 compounds, particularly 9t, 9c, and 9a, demonstrate high potential as dual-target antimicrobial drug candidates. Further optimization may enhance their therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsAntitubercular AgentsAnti-Bacterial AgentsStructure-Activity RelationshipMicrobial Sensitivity TestsMycobacterium tuberculosisMolecular Docking SimulationStaphylococcus aureusDNA GyraseBacillus subtilisEscherichia coliHumansOxidoreductasesBacterial Proteins

Stichwörter der Autor:innen

Coumarin derivativesantimicrobial activityantitubercular agentsmolecular docking studiesstructure–activity relationship (SAR)thiophene-based compounds

Substanzen

CoumarinsAntitubercular AgentsDNA GyrasecoumarinAnti-Bacterial AgentsOxidoreductasesInhA protein, MycobacteriumBacterial Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Christ College, Rajkot, India.
  • Department of Chemistry, Saurashtra University, Rajkot, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Combi-Chem Bio-Resource Center, Organic Chemistry Division, CSIR-National Chemical Laboratory, Pune, India.
  • Department of Microbiology, Christ College, Rajkot, India.
  • In Silico Lab, Department of Microbiology, School of Science, RK University, Rajkot, India.

Zitieren

APA

Bavishi, A., Vala, H., Thakrar, S., Swami, S., Sarkar, D., Shukla, R., Kamdar, J., & Shah, A. (2025). Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2025.2504331

Vancouver

Bavishi A, Vala H, Thakrar S, Swami S, Sarkar D, Shukla R, et al. Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies. Future Medicinal Chemistry. 2025. doi:10.1080/17568919.2025.2504331

BibTeX
@article{Bavishi2025,
  author = {Bavishi, Abhay and Vala, Hardev and Thakrar, Shailesh and Swami, Sagar and Sarkar, Dhiman and Shukla, Rushit and Kamdar, Jignesh and Shah, Anamik},
  title = {Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies},
  journal = {Future Medicinal Chemistry},
  year = {2025},
  doi = {10.1080/17568919.2025.2504331}
}
Kostenlos starten →